Filed 1mo ago· May 1, 2026
23 days to disclose
Lizzie Fletcher
DHouseTexas-07
↓sold
Eli Lilly
LLY
$1K-$15K
−0.8% vs S&P 500
Trade dateApr 8, 2026
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 140
Filed 1mo ago· Apr 7, 2026
35 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Pfizer
PFE
$1K-$15K
+5.1% vs S&P 500
Trade dateMar 3, 2026
Pfizer, Inc.
Filed 2mo ago· Mar 25, 2026
50 days to disclose · 5 past 45-day window
Susan M. Collins
RSenateMaine
↑bought
Pfizer
PFE
$15K-$50K
Trade dateFeb 3, 2026
Bond⚑ Pharmaceutical
Filed 2mo ago· Mar 9, 2026
19 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
−5.8% vs S&P 500
Trade dateFeb 18, 2026
Pfizer, Inc.
Filed 4mo ago· Jan 23, 2026
23 days to disclose
J. French Hill
RHouseArkansas-02
↓sold
Pfizer
PFE
$15K-$30K
−4.1% vs S&P 500
Trade dateDec 31, 2025
Pfizer, Inc.
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day window
Julia Letlow
RHouseLouisiana-05
↑bought
Pfizer
PFE
$1K-$15K
−6.8% vs S&P 500
Trade dateOct 23, 2024
Pfizer, Inc.
Filed 4mo ago· Jan 12, 2026
32 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
−3.3% vs S&P 500
Trade dateDec 11, 2025
Pfizer, Inc.
Filed 8mo ago· Sep 12, 2025
38 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
+12.1% vs S&P 500
Trade dateAug 5, 2025
Pfizer, Inc.
Filed 8mo ago· Sep 12, 2025
39 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
Pfizer
PFE
$1K-$15K
+11.7% vs S&P 500
Trade dateAug 4, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Filed 9mo ago· Aug 14, 2025
10 days to disclose
Scott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$15K-$50K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 13, 2025
34 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Pfizer
PFE
$1K-$15K
+8.9% vs S&P 500
Trade dateJul 10, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Filed 10mo ago· Jul 16, 2025
42 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↓sold
Pfizer
PFE
$1K-$15K
+11.4% vs S&P 500
Trade dateJun 4, 2025
Pfizer, Inc.
Filed 10mo ago· Jul 14, 2025
28 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+9.4% vs S&P 500
Trade dateJun 16, 2025
Filed 10mo ago· Jul 14, 2025
28 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Merck
MRK
$1K-$15K
+9.4% vs S&P 500
Trade dateJun 16, 2025
Stock
Filed 11mo ago· Jul 3, 2025
9 days to disclose
Virginia Foxx
RHouseNorth Carolina-05
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+11.0% vs S&P 500
Trade dateJun 24, 2025
Common Stock
⚑ Pharmaceutical
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day windowScott Franklin
RHouseFlorida-18
↑bought
Merck
MRK
$1K-$15K
−0.8% vs S&P 500
Trade dateAug 7, 2024
Stock
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day windowScott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$1K-$15K
+3.1% vs S&P 500
Trade dateAug 7, 2024
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day windowScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+43.9% vs S&P 500
Trade dateAug 7, 2024
Filed 11mo ago· Jul 2, 2025
29 days to disclose
Ron Wyden
DSenateOregon
↓sold
Pfizer
PFE
$1K-$15K
+11.6% vs S&P 500
Trade dateJun 3, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Filed 12mo ago· Jun 6, 2025
8 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
+12.2% vs S&P 500
Trade dateMay 29, 2025
Pfizer, Inc.
Filed 1.1y ago· May 12, 2025
21 days to disclose
Bruce Westerman
RHouseArkansas-04
↓sold
Pfizer
PFE
$1K-$15K
+12.0% vs S&P 500
Trade dateApr 21, 2025
Pfizer, Inc.
Filed 1.1y ago· May 8, 2025
31 days to disclose
Jefferson Shreve
RHouseIndiana-06
↑bought
Pfizer
PFE
$15K-$30K
+6.8% vs S&P 500
Trade dateApr 7, 2025
Pfizer, Inc.
Filed 1.1y ago· May 6, 2025
8 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Pfizer
PFE
$1K-$15K
+7.9% vs S&P 500
Trade dateApr 28, 2025
Pfizer, Inc.
Filed 1.1y ago· Apr 28, 2025
20 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Pfizer
PFE
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Filed 1.1y ago· Apr 16, 2025
44 days to discloseBruce Westerman
RHouseArkansas-04
↑bought
Pfizer
PFE
$1K-$15K
+1.8% vs S&P 500
Trade dateMar 3, 2025
Pfizer, Inc.
Filed 1.1y ago· Apr 11, 2025
15 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−37.2% vs S&P 500
Trade dateMar 27, 2025
Filed 1.1y ago· Apr 11, 2025
15 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$15K-$50K
−37.2% vs S&P 500
Trade dateMar 27, 2025
Filed 1.1y ago· Apr 11, 2025
32 days to disclose
Carol D. Miller
RHouseWest Virginia-01
↓sold
Pfizer
PFE
$1K-$15K
+0.6% vs S&P 500
Trade dateMar 10, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Filed 1.2y ago· Apr 7, 2025
6 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Pfizer
PFE
$15K-$50K
+4.5% vs S&P 500
Trade dateApr 1, 2025
Pfizer, Inc.
Filed 1.2y ago· Mar 12, 2025
16 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
Pfizer
PFE
$1K-$15K
+0.6% vs S&P 500
Trade dateFeb 24, 2025
Pfizer, Inc.
Filed 1.2y ago· Mar 6, 2025
8 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
+0.5% vs S&P 500
Trade dateFeb 26, 2025
Pfizer, Inc.
Filed 1.2y ago· Mar 6, 2025
21 days to disclose
John Boozman
RSenateArkansas
↓sold
Pfizer
PFE
$1K-$15K
+1.4% vs S&P 500
Trade dateFeb 13, 2025
Filed 1.3y ago· Feb 12, 2025
30 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Pfizer
PFE
$1K-$15K
+5.0% vs S&P 500
Trade dateJan 13, 2025
Pfizer, Inc.
Filed 1.3y ago· Feb 11, 2025
18 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Pfizer, Inc.
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+52.0% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Amgen
AMGN
$1K-$15K
+18.4% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
AbbVie
ABBV
$1K-$15K
+21.2% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−10.8% vs S&P 500
Trade dateDec 6, 2024
Common Stock
⚑ Pharmaceutical
Filed 1.5y ago· Nov 21, 2024
34 days to disclose
Laurel M. Lee
RHouseFlorida-15
↔exchanged
Pfizer
PFE
$100K-$200K
Trade dateOct 18, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 1.6y ago· Nov 14, 2024
30 days to disclose
Greg Landsman
DHouseOhio-01
↓sold
Pfizer
PFE
$15K-$50K
−2.8% vs S&P 500
Trade dateOct 15, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 1.7y ago· Sep 4, 2024
6 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
Pfizer
PFE
$15K-$50K
−2.8% vs S&P 500
Trade dateAug 29, 2024
Pfizer, Inc.
Filed 1.8y ago· Aug 21, 2024
404 days to disclose · 359 past 45-day window
Jared Moskowitz
DHouseFlorida-23
↑bought
Pfizer
PFE
$1K-$15K
−39.7% vs S&P 500
Trade dateJul 14, 2023
Pfizer, Inc.
Filed 1.8y ago· Aug 20, 2024
13 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+43.9% vs S&P 500
Trade dateAug 7, 2024
Filed 1.8y ago· Aug 20, 2024
13 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$50K-$100K
+3.1% vs S&P 500
Trade dateAug 7, 2024
Filed 1.8y ago· Aug 20, 2024
14 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Pfizer
PFE
$15K-$50K
+0.7% vs S&P 500
Trade dateAug 6, 2024
Pfizer, Inc.
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+47.1% vs S&P 500
Trade dateAug 2, 2024
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Merck
MRK
$1K-$15K
Trade dateAug 2, 2024
Stock
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$1K-$15K
+1.1% vs S&P 500
Trade dateAug 2, 2024
Filed 1.8y ago· Aug 6, 2024
403 days to disclose · 358 past 45-day window
David P. Joyce
RHouseOhio-14
↓sold
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$15K-$50K
+11.9% vs S&P 500
Trade dateJun 30, 2023
ETF
Filed 2.0y ago· Jun 14, 2024
42 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Pfizer
PFE
$15K-$50K
+42.5% vs S&P 500
Trade dateMay 3, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.0y ago· Jun 12, 2024
103 days to disclose · 58 past 45-day window
Roger Williams
RHouseTexas-25
↓sold
Pfizer
PFE
$1K-$15K
+37.7% vs S&P 500
Trade dateMar 1, 2024
Pfizer, Inc.
Filed 2.0y ago· Jun 12, 2024
103 days to disclose · 58 past 45-day windowRoger Williams
RHouseTexas-25
↑bought
Pfizer
PFE
$1K-$15K
−37.7% vs S&P 500
Trade dateMar 1, 2024
Pfizer, Inc.
Filed 2.0y ago· Jun 12, 2024
713 days to disclose · 668 past 45-day windowRoger Williams
RHouseTexas-25
↑bought
Sunshine Biopharma
SBFM
$1K-$15K
−189.2% vs S&P 500
Trade dateJun 30, 2022
stock
Filed 2.0y ago· Jun 12, 2024
1078 days to disclose · 1033 past 45-day windowRoger Williams
RHouseTexas-25
↑bought
Pfizer
PFE
$1K-$15K
−97.8% vs S&P 500
Trade dateJun 30, 2021
Pfizer, Inc.
Filed 2.2y ago· Mar 15, 2024
17 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−40.4% vs S&P 500
Trade dateFeb 27, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.3y ago· Mar 2, 2024
19 days to disclose
Earl Blumenauer
—HouseOregon-03
↑bought
Pfizer
PFE
$1K-$15K
−44.9% vs S&P 500
Trade dateFeb 12, 2024
Pfizer, Inc.
Filed 2.4y ago· Jan 22, 2024
25 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Pfizer
PFE
$1K-$15K
−16.9% vs S&P 500
Trade dateDec 28, 2023
Filed 2.4y ago· Jan 22, 2024
25 days to discloseJared Moskowitz
DHouseFlorida-23
↓sold
Pfizer
PFE
$1K-$15K
+9.0% vs S&P 500
Trade dateDec 28, 2023
Filed 2.4y ago· Jan 18, 2024
38 days to disclose
Sheldon Whitehouse
DSenateRhode Island
↓sold
Pfizer
PFE
$1K-$15K
+11.7% vs S&P 500
Trade dateDec 11, 2023
⚑ Pharmaceutical
Filed 2.4y ago· Jan 17, 2024
34 days to disclose
Jerry Moran
RSenateKansas
↓sold
Pfizer
PFE
$1K-$15K
+9.8% vs S&P 500
Trade dateDec 14, 2023
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.4y ago· Jan 12, 2024
25 days to disclose
Shelley Moore Capito
RSenateWest Virginia
↓sold
Pfizer
PFE
$1K-$15K
+10.3% vs S&P 500
Trade dateDec 18, 2023
⚑ Pharmaceutical
Filed 2.4y ago· Jan 12, 2024
31 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Pfizer
PFE
$1K-$15K
+11.2% vs S&P 500
Trade dateDec 12, 2023
Filed 2.4y ago· Jan 8, 2024
19 days to discloseJohn Boozman
RSenateArkansas
↑bought
Pfizer
PFE
$1K-$15K
−15.9% vs S&P 500
Trade dateDec 20, 2023
Filed 2.4y ago· Jan 8, 2024
19 days to discloseJohn Boozman
RSenateArkansas
↑bought
Pfizer
PFE
$1K-$15K
−15.9% vs S&P 500
Trade dateDec 20, 2023
Filed 2.6y ago· Oct 12, 2023
31 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Pfizer
PFE
$15K-$50K
+11.7% vs S&P 500
Trade dateSep 11, 2023
Filed 2.6y ago· Oct 12, 2023
31 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Merck
MRK
$15K-$50K
+11.7% vs S&P 500
Trade dateSep 11, 2023
Stock
Filed 2.6y ago· Oct 12, 2023
31 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+11.7% vs S&P 500
Trade dateSep 11, 2023
Filed 2.6y ago· Oct 10, 2023
32 days to disclose
Lois Frankel
DHouseFlorida-22
↓sold
Pfizer
PFE
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
Filed 2.6y ago· Oct 10, 2023
32 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
Stock
Filed 2.6y ago· Oct 10, 2023
32 days to discloseLois Frankel
DHouseFlorida-22
↓sold
AbbVie
ABBV
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
Filed 2.6y ago· Oct 10, 2023
32 days to discloseLois Frankel
DHouseFlorida-22
↓sold
AbbVie
ABBV
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
Filed 2.6y ago· Oct 10, 2023
34 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+13.0% vs S&P 500
Trade dateSep 6, 2023
Filed 2.6y ago· Oct 10, 2023
34 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+13.0% vs S&P 500
Trade dateSep 6, 2023
Stock
Filed 2.6y ago· Oct 10, 2023
41 days to discloseLois Frankel
DHouseFlorida-22
↑bought
AbbVie
ABBV
$1K-$15K
+37.3% vs S&P 500
Trade dateAug 30, 2023
Filed 2.7y ago· Sep 5, 2023
7 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↓sold
Takeda Pharmaceutical
TAK
$15K-$50K
+58.9% vs S&P 500
Trade dateAug 29, 2023
Limited American Depositary Shares
⚑ Pharmaceutical
Filed 2.8y ago· Aug 26, 2023
16 days to discloseLois Frankel
DHouseFlorida-22
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+24.2% vs S&P 500
Trade dateAug 10, 2023
Filed 2.8y ago· Aug 26, 2023
24 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+11.2% vs S&P 500
Trade dateAug 2, 2023
Stock
Filed 2.8y ago· Aug 14, 2023
20 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−83.9% vs S&P 500
Trade dateJul 25, 2023
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.8y ago· Aug 10, 2023
149 days to disclose · 104 past 45-day window
Rick W. Allen
RHouseGeorgia-12
↓sold
Pfizer
PFE
$15K-$50K
+17.5% vs S&P 500
Trade dateMar 14, 2023
⚑ Pharmaceutical
Filed 2.8y ago· Aug 10, 2023
1266 days to disclose · 1221 past 45-day windowRick W. Allen
RHouseGeorgia-12
↑bought
Pfizer
PFE
$15K-$50K
Trade dateFeb 21, 2020
⚑ Pharmaceutical
Filed 2.9y ago· Jul 28, 2023
16 days to discloseLois Frankel
DHouseFlorida-22
↑bought
Pfizer
PFE
$1K-$15K
−40.8% vs S&P 500
Trade dateJul 12, 2023
Filed 2.9y ago· Jul 28, 2023
30 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+13.8% vs S&P 500
Trade dateJun 28, 2023
Stock
Filed 2.9y ago· Jul 14, 2023
32 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−96.9% vs S&P 500
Trade dateJun 12, 2023
Pfizer, Inc.
⚑ Pharmaceutical
Filed 3.0y ago· Jun 6, 2023
12 days to disclose
Zoe Lofgren
DHouseCalifornia-18
↓sold
Pfizer
PFE
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Filed 3.0y ago· May 19, 2023
39 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Amicus Therapeutics
FOLD
$1K-$15K
+43.5% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Pfizer
PFE
$15K-$50K
−47.7% vs S&P 500
Trade dateApr 10, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Pfizer
PFE
$1K-$15K
+16.9% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Pfizer
PFE
$1K-$15K
+16.9% vs S&P 500
Trade dateMar 7, 2023
Filed 3.2y ago· Apr 4, 2023
34 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↓sold
GSK PLC
GSK
$50K-$100K
+80.8% vs S&P 500
Trade dateMar 1, 2023
JT GSK plc American Depositary Shares
⚑ Pharmaceutical
Filed 3.2y ago· Mar 13, 2023
21 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Pfizer
PFE
$1K-$15K
+14.0% vs S&P 500
Trade dateFeb 20, 2023
Filed 3.2y ago· Mar 13, 2023
24 days to discloseLois Frankel
DHouseFlorida-22
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+33.9% vs S&P 500
Trade dateFeb 17, 2023
Filed 3.2y ago· Mar 10, 2023
17 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Pfizer
PFE
$1K-$15K
−51.9% vs S&P 500
Trade dateFeb 21, 2023
Filed 3.3y ago· Mar 3, 2023
15 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Takeda Pharmaceutical
TAK
$1K-$15K
−69.0% vs S&P 500
Trade dateFeb 16, 2023
Limited American Depositary Shares
⚑ Pharmaceutical
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Fate Therapeutics
FATE
$1K-$15K
−72.3% vs S&P 500
Trade dateJan 31, 2023
Filed 3.5y ago· Dec 16, 2022
43 days to discloseSusan M. Collins
RSenateMaine
↑bought
Biogen
BIIB
$15K-$50K
Trade dateNov 3, 2022
Bond⚑ Pharmaceutical
Filed 3.5y ago· Dec 6, 2022
35 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Takeda Pharmaceutical
TAK
$1K-$15K
−61.6% vs S&P 500
Trade dateNov 1, 2022
Limited American Depositary Shares
⚑ Pharmaceutical
Filed 3.5y ago· Nov 18, 2022
9 days to discloseLois Frankel
DHouseFlorida-22
↑bought
Pfizer
PFE
$1K-$15K
−56.2% vs S&P 500
Trade dateNov 9, 2022
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 1, 2026 1mo ago | Lizzie Fletcher DHouseTexas-07 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Apr 8, 2026 23 days to disclose | Flat·+0.0% −0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Pfizer PFE Pfizer, Inc. | Mar 3, 2026 35 days to disclose | Flat·-0.2% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 25, 2026 2mo ago | Susan M. Collins RSenateMaine | ↑bought | Pfizer PFE Bond⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Feb 3, 2026 50 days to disclose · 5 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Mar 9, 2026 2mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Feb 18, 2026 19 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 23, 2026 4mo ago | J. French Hill RHouseArkansas-02 | ↓sold | Pfizer PFE Pfizer, Inc. | Dec 31, 2025 23 days to disclose | Flat·+0.0% −4.1% vs S&P 500 | $15K-$30K midpoint $22.5K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Pfizer PFE Pfizer, Inc. | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Bad buy·−$646-8.1% −6.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Dec 11, 2025 32 days to disclose | Flat·+0.0% −3.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Aug 5, 2025 38 days to disclose | Flat·+0.0% +12.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$2K-6.2% −17.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 10, 2025 34 days to disclose | Flat·+0.0% +8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 16, 2025 10mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Pfizer PFE Pfizer, Inc. | Jun 4, 2025 42 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | Scott Franklin RHouseFlorida-18 | ↓sold | Johnson & Johnson JNJ | Jun 16, 2025 28 days to disclose | Flat·+0.0% +9.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 14, 2025 10mo ago | Scott Franklin RHouseFlorida-18 | ↓sold | Merck MRK Stock | Jun 16, 2025 28 days to disclose | Flat·+0.0% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Virginia Foxx RHouseNorth Carolina-05 | ↓sold | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 9 days to disclose | Flat·+0.0% +11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Merck MRK Stock | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$76+1.0% −0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$386+4.8% +3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$3.6K+45.6% +43.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 2, 2025 11mo ago | Ron Wyden DSenateOregon | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Finance | Jun 3, 2025 29 days to disclose | Flat·+0.0% +11.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2025 12mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | May 29, 2025 8 days to disclose | Flat·+0.0% +12.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↓sold | Pfizer PFE Pfizer, Inc. | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Pfizer PFE Pfizer, Inc. | Apr 7, 2025 31 days to disclose | Good buy·+$3.9K+17.2% +6.8% vs S&P 500 | $15K-$30K midpoint $22.5K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Pfizer PFE Pfizer, Inc. | Apr 28, 2025 8 days to disclose | Good buy·+$1.2K+15.1% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↑bought | Pfizer PFE Pfizer, Inc. | Mar 3, 2025 44 days to disclose | Good buy·+$85+1.1% +1.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Mar 27, 2025 15 days to disclose | Bad buy·−$2.8K-34.8% −37.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Mar 27, 2025 15 days to disclose | Bad buy·−$11.3K-34.8% −37.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Ways and Means | Mar 10, 2025 32 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Pfizer PFE Pfizer, Inc. | Apr 1, 2025 6 days to disclose | Good buy·+$2.6K+8.1% +4.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 12, 2025 1.2y ago | Julie Johnson DHouseTexas-32 | ↓sold | Pfizer PFE Pfizer, Inc. | Feb 24, 2025 16 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Feb 26, 2025 8 days to disclose | Flat·+0.0% +0.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | John Boozman RSenateArkansas | ↓sold | Pfizer PFE | Feb 13, 2025 21 days to disclose | Flat·+0.0% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 12, 2025 1.3y ago | Julie Johnson DHouseTexas-32 | ↓sold | Pfizer PFE Pfizer, Inc. | Jan 13, 2025 30 days to disclose | Flat·+0.0% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Jan 24, 2025 18 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$4.4K+54.9% +52.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$1.7K+21.3% +18.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$1.9K+24.1% +21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Bad buy·−$633-7.9% −10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2024 1.5y ago | Laurel M. Lee RHouseFlorida-15 | ↔exchanged | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Energy and Commerce | Oct 18, 2024 34 days to disclose | price pending | $100K-$200K midpoint $150K |
Nov 14, 2024 1.6y ago | Greg Landsman DHouseOhio-01 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Energy and Commerce | Oct 15, 2024 30 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 4, 2024 1.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Pfizer PFE Pfizer, Inc. | Aug 29, 2024 6 days to disclose | Bad buy·−$2.5K-7.6% −2.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 21, 2024 1.8y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Pfizer PFE Pfizer, Inc. | Jul 14, 2023 404 days to disclose · 359 past 45-day window | Bad buy·−$2.2K-27.0% −39.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2024 13 days to disclose | Good buy·+$14.8K+45.6% +43.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 7, 2024 13 days to disclose | Good buy·+$3.6K+4.8% +3.1% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Pfizer PFE Pfizer, Inc. | Aug 6, 2024 14 days to disclose | Flat·+0.0% +0.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 2, 2024 18 days to disclose | Good buy·+$3.6K+45.5% +47.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Merck MRK Stock | Aug 2, 2024 18 days to disclose | Bad buy·−$114-1.4% | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 2, 2024 18 days to disclose | Flat·-0.4% +1.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 6, 2024 1.8y ago | David P. Joyce RHouseOhio-14 | ↓sold | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI ETF | Jun 30, 2023 403 days to disclose · 358 past 45-day window | Flat·+0.0% +11.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 3, 2024 42 days to disclose | Smart sell·+$947+2.9% +42.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 12, 2024 2.0y ago | Roger Williams RHouseTexas-25 | ↓sold | Pfizer PFE Pfizer, Inc. | Mar 1, 2024 103 days to disclose · 58 past 45-day window | Missed gain·−$123-1.5% +37.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 12, 2024 2.0y ago | Roger Williams RHouseTexas-25 | ↑bought | Pfizer PFE Pfizer, Inc. | Mar 1, 2024 103 days to disclose · 58 past 45-day window | Good buy·+$123+1.5% −37.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 12, 2024 2.0y ago | Roger Williams RHouseTexas-25 | ↑bought | Sunshine Biopharma SBFM stock | Jun 30, 2022 713 days to disclose · 668 past 45-day window | Bad buy·−$8K-100.0% −189.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 12, 2024 2.0y ago | Roger Williams RHouseTexas-25 | ↑bought | Pfizer PFE Pfizer, Inc. | Jun 30, 2021 1078 days to disclose · 1033 past 45-day window | Bad buy·−$2.5K-31.1% −97.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 15, 2024 2.2y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Feb 27, 2024 17 days to disclose | Flat·+0.4% −40.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 2, 2024 2.3y ago | Earl Blumenauer —HouseOregon-03 | ↑bought | Pfizer PFE Pfizer, Inc. | Feb 12, 2024 19 days to disclose | Bad buy·−$191-2.4% −44.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Pfizer PFE | Dec 28, 2023 25 days to disclose | Bad buy·−$628-7.8% −16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Pfizer PFE | Dec 28, 2023 25 days to disclose | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 18, 2024 2.4y ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Pfizer PFE ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 11, 2023 38 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 17, 2024 2.4y ago | Jerry Moran RSenateKansas | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 34 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2024 2.4y ago | Shelley Moore Capito RSenateWest Virginia | ↓sold | Pfizer PFE ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 18, 2023 25 days to disclose | Flat·+0.0% +10.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2024 2.4y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Pfizer PFE | Dec 12, 2023 31 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2024 2.4y ago | John Boozman RSenateArkansas | ↑bought | Pfizer PFE | Dec 20, 2023 19 days to disclose | Bad buy·−$319-4.0% −15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2024 2.4y ago | John Boozman RSenateArkansas | ↑bought | Pfizer PFE | Dec 20, 2023 19 days to disclose | Bad buy·−$319-4.0% −15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Pfizer PFE | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Merck MRK Stock | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Johnson & Johnson JNJ | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Pfizer PFE | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | AbbVie ABBV | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | AbbVie ABBV | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Johnson & Johnson JNJ | Sep 6, 2023 34 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Sep 6, 2023 34 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↑bought | AbbVie ABBV | Aug 30, 2023 41 days to disclose | Good buy·+$3.8K+47.4% +37.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 5, 2023 2.7y ago | Virginia Foxx RHouseNorth Carolina-05 | ↓sold | Takeda Pharmaceutical TAK Limited American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 29, 2023 7 days to disclose | Flat·+0.0% +58.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 26, 2023 2.8y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | Aug 10, 2023 16 days to disclose | Good buy·+$2.7K+34.3% +24.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 26, 2023 2.8y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Aug 2, 2023 24 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2023 2.8y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jul 25, 2023 20 days to disclose | Bad buy·−$2.2K-27.1% −83.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↓sold | Pfizer PFE ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Mar 14, 2023 149 days to disclose · 104 past 45-day window | Flat·+0.0% +17.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↑bought | Pfizer PFE ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Feb 21, 2020 1266 days to disclose · 1221 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Jul 28, 2023 2.9y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Pfizer PFE | Jul 12, 2023 16 days to disclose | Bad buy·−$2.1K-26.3% −40.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 28, 2023 2.9y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Jun 28, 2023 30 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2023 2.9y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jun 12, 2023 32 days to disclose | Bad buy·−$2.6K-32.3% −96.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Pfizer PFE | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Amicus Therapeutics FOLD | Apr 10, 2023 39 days to disclose | Missed gain·−$2.5K-30.8% +43.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Pfizer PFE | Apr 10, 2023 39 days to disclose | Bad buy·−$11.8K-36.4% −47.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Pfizer PFE | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Pfizer PFE | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 4, 2023 3.2y ago | Virginia Foxx RHouseNorth Carolina-05 | ↓sold | GSK PLC GSK JT GSK plc American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Mar 1, 2023 34 days to disclose | Flat·+0.0% +80.8% vs S&P 500 | $50K-$100K midpoint $75K |
Mar 13, 2023 3.2y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Pfizer PFE | Feb 20, 2023 21 days to disclose | Flat·+0.0% +14.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 13, 2023 3.2y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | Feb 17, 2023 24 days to disclose | Good buy·+$3.7K+46.4% +33.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 10, 2023 3.2y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Pfizer PFE | Feb 21, 2023 17 days to disclose | Bad buy·−$3K-37.9% −51.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 3, 2023 3.3y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Takeda Pharmaceutical TAK Limited American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Feb 16, 2023 15 days to disclose | Good buy·+$468+5.8% −69.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Fate Therapeutics FATE | Jan 31, 2023 24 days to disclose | Bad buy·−$4.9K-60.9% −72.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 16, 2022 3.5y ago | Susan M. Collins RSenateMaine | ↑bought | Biogen BIIB Bond⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 3, 2022 43 days to disclose | price pending | $15K-$50K midpoint $32.5K |
Dec 6, 2022 3.5y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Takeda Pharmaceutical TAK Limited American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Nov 1, 2022 35 days to disclose | Good buy·+$1.9K+24.0% −61.6% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 18, 2022 3.5y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Pfizer PFE | Nov 9, 2022 9 days to disclose | Bad buy·−$3.5K-43.2% −56.2% vs S&P 500 | $1K-$15K midpoint $8K |